Biography Sumitra Miriyala is a graduate of the MS program in Biochemistry and the Ph.D. program in Biochemistry and Cardiology at the University of Madras. She began her research in redox biology during her graduate studies at the University of Madras, where she focused on complement activation in acute myocardial infarction. Later as a postdoctoral fellow, she carried out experiments studying lysolipids function in the vasculature by developing tissue-specific and inducible knockout mice at the University of Kentucky and Emory University. Since joining Dr. Daret St. Clair laboratory as a research scholar, she has focused on the mechanisms of Doxorubicin cardiotoxicity by analyzing mitochondrial bioenergetics. Her career track record is outstanding with 51+ peer-reviewed publications in such journals as Circulation, Journal of Biological Chemistry, Circulation Research and receiving prominent awards like the Young Investigator Award from the International Society for Heart Research.
She is actively involved in the Society of Free Redox Biology and Medicine (SFRBM), where she has given several oral presentations and co-chaired several annual meetings special events as a junior faculty recently. She also has served as a guest editor for the journal Oxidative and Cellular Longevity. Dr. Miriyala is an active member of the Women's Leadership Committee at the Arteriosclerosis, Thrombosis, and Vascular Biology Council (ATVB). Dr. Miriyala came to the LSU Health Sciences Center-Shreveport in January 2013 at the rank of Assistant Professor research series and later promoted to tenure-track in the Department of Cellular Biology and Anatomy in 2016.
She is the director of the Anatomy Laboratory for training the MD/Ph.D. students and fellow residents. As an active member of the Departmental Graduate Committee, she is in charge of MS/Ph.D. student recruitment program for the Cellular Biology and Anatomy. While an Assistant Professor at LSUHSC, she obtained intramural funding as well as an SFRBM mini-fellowship to look at the role of reactive oxygen species in the cardiovascular, indicators not only of her dedication and commitment to research but also her sound research abilities. Dr. Miriyala laboratory is funded by extramural agencies (NIH, AHA, American Diabetic Association) since 2007. The current NIH grant focuses on the effect of Doxorubicin on the myocardial lipid regulation.
© 2019 LSUHSC. All Rights Reserved. Website Design by GroupM7 Design™